Jon Bernardini

Co-Founder & Chief Executive Officer Proxima Bio

Jon co-founded Proxima Bio with Jase in 2023 whilst working as a cell biologist at WEHI. Jon is responsible for translating the company’s exciting science into new medicines and a thriving biotech business.

He is also responsible for strategic partnerships and business development at Proxima. Jon is passionate about growing Australia’s biotech ecosystem by encouraging more scientists to join spinouts and commercially focused programs.

Jon has been working in the field of protein degradation for over a decade. He has extensive experience in cellular models of neurodegeneration and genetic diseases, with a PhD from the University of Melbourne. He has also held research roles at WEHI and the University of British Columbia.

Seminars

Friday 27th February 2026
The Next Generation of Validated Protein Degradation
8:40 am
  • Optimizing physical chemical properties for more favourable ADME characteristics of TACs
  • Leveraging PROTACs as binders for antibodies, as well as payloads
  • Discussing rationally designing candidates that break out of the structural constraints of E3 ligases
jon bernadini speaker at Therapies Partnering & Licensing Summit Asia